17 results on '"Cohen, Joshua M."'
Search Results
2. Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
3. Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
4. Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
5. A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
6. Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
7. Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
8. Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial
9. Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
10. Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
11. The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
12. Efficacy and quality‐of‐life improvements with fremanezumab treatment in patients with difficult‐to‐treat migraine with associated neurological dysfunction.
13. Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid.
14. Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine.
15. Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.
16. Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
17. Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.